Artykuły w czasopismach na temat „HDAC 3”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „HDAC 3”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Bertos, Nicholas R., Audrey H. Wang i Xiang-Jiao Yang. "Class II histone deacetylases: Structure, function, and regulation". Biochemistry and Cell Biology 79, nr 3 (1.06.2001): 243–52. http://dx.doi.org/10.1139/o01-032.
Pełny tekst źródłaOzawa, Yukiyasu, Masayuki Towatari, Shinobu Tsuzuki, Fumihiko Hayakawa, Takahiro Maeda, Yasuhiko Miyata, Mitsune Tanimoto i Hidehiko Saito. "Histone deacetylase 3 associates with and represses the transcription factor GATA-2". Blood 98, nr 7 (1.10.2001): 2116–23. http://dx.doi.org/10.1182/blood.v98.7.2116.
Pełny tekst źródłaStubbs, Matthew C., Won-Il Kim, Tina Davis, Jun Qi, James Bradner, Andrew L. Kung i Scott A. Armstrong. "Selective Inhibition of HDAC1 and HDAC2 Is a Potential Therapeutic Option for B-All". Blood 116, nr 21 (19.11.2010): 2900. http://dx.doi.org/10.1182/blood.v116.21.2900.2900.
Pełny tekst źródłaVarricchio, Lilian, Carmela Dell'Aversana, Angela Nebbioso, Giovanni Migliaccio, Lucia Altucci, James J. Bieker i Anna Rita F. Migliaccio. "Identification of a New Functional HDAC Complex Composed by HDAC5, GATA1 and EKLF in Human Erythroid Cells". Blood 120, nr 21 (16.11.2012): 979. http://dx.doi.org/10.1182/blood.v120.21.979.979.
Pełny tekst źródłaMigliaccio, Giovanni, Carmela Dell’Aversana, Angela Nebbioso, Elena Alfani, Lilian arricchio, Antonello Mai, Pratima Chaurasia i in. "Ontogenic-Specific Increasesin HDAC1 Activity and Transcription Factor Association During the Maturation of Human Adult Erythroblasts in Vitro." Blood 114, nr 22 (1.11.2009): 1978. http://dx.doi.org/10.1182/blood.v114.22.1978.1978.
Pełny tekst źródłaHess, Lena, Verena Moos, Arnel A. Lauber, Wolfgang Reiter, Michael Schuster, Natascha Hartl, Daniel Lackner i in. "A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation". PLOS Genetics 18, nr 8 (22.08.2022): e1010376. http://dx.doi.org/10.1371/journal.pgen.1010376.
Pełny tekst źródłaKeedy, Kara S., Nancie M. Archin, Adam T. Gates, Amy Espeseth, Daria J. Hazuda i David M. Margolis. "A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression". Journal of Virology 83, nr 10 (11.03.2009): 4749–56. http://dx.doi.org/10.1128/jvi.02585-08.
Pełny tekst źródłaMasselli, Elena, Lilian Varricchio, Barbara Ghinassi, Carolyn Whitsett, Patricia A. Shi i Anna Rita F. Migliaccio. "Class IIa HDAC Inhibitors Reduce HDAC1 Activity by off-Target Effects Which Reduce GATA1 Expression In Human Erythroblasts Expanded Ex-Vivo". Blood 116, nr 21 (19.11.2010): 4780. http://dx.doi.org/10.1182/blood.v116.21.4780.4780.
Pełny tekst źródłaIbrahim, Hany S., Mohamed Abdelsalam, Yanira Zeyn, Matthes Zessin, Al-Hassan M. Mustafa, Marten A. Fischer, Patrik Zeyen i in. "Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity". International Journal of Molecular Sciences 23, nr 1 (29.12.2021): 369. http://dx.doi.org/10.3390/ijms23010369.
Pełny tekst źródłaAngiolilli, Chiara, Pawel A. Kabala, Aleksander M. Grabiec, Iris M. Van Baarsen, Bradley S. Ferguson, Samuel García, Beatriz Malvar Fernandez i in. "Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes". Annals of the Rheumatic Diseases 76, nr 1 (25.07.2016): 277–85. http://dx.doi.org/10.1136/annrheumdis-2015-209064.
Pełny tekst źródłaIhlefeld, Katja, Ralf Frederik Claas, Alexander Koch, Josef M. Pfeilschifter i Dagmar Meyer zu Heringdorf. "Evidence for a link between histone deacetylation and Ca2+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts". Biochemical Journal 447, nr 3 (5.10.2012): 457–64. http://dx.doi.org/10.1042/bj20120811.
Pełny tekst źródłaBaumann, Philipp, Carmen Junghanns, Strobl Stefan, Fuat Oduncu i Ralf Schmidmaier. "The Novel Pan-HDAC Inhibitor CR2408 Inhibits Multiple Myeloma Cell Growth and Proliferation". Blood 118, nr 21 (18.11.2011): 5133. http://dx.doi.org/10.1182/blood.v118.21.5133.5133.
Pełny tekst źródłaMcKinsey, Timothy A., Chun Li Zhang i Eric N. Olson. "Identification of a Signal-Responsive Nuclear Export Sequence in Class II Histone Deacetylases". Molecular and Cellular Biology 21, nr 18 (15.09.2001): 6312–21. http://dx.doi.org/10.1128/mcb.21.18.6312-6321.2001.
Pełny tekst źródłaKim, Jwa-Young, Hae-Yong Kweon, Dae-Won Kim, Je-Yong Choi i Seong-Gon Kim. "4-Hexylresorcinol Inhibits Class I Histone Deacetylases in Human Umbilical Cord Endothelial Cells". Applied Sciences 11, nr 8 (13.04.2021): 3486. http://dx.doi.org/10.3390/app11083486.
Pełny tekst źródłaXiao, Yufeng, Seth Hale, Nikee Awasthee, Xuan Zhang, Yi Liu, Zhiguang Huo, Dongwen Lyu i in. "Abstract 5347: Selective targeting deacetylase 3 (HDAC3) and HDAC8 by PROTACs". Cancer Research 83, nr 7_Supplement (4.04.2023): 5347. http://dx.doi.org/10.1158/1538-7445.am2023-5347.
Pełny tekst źródłaLaschanzky, Richard S., Lisa E. Humphrey, Jihyun Ma, Lynette M. Smith, Thomas J. Enke, Surendra K. Shukla, Aneesha Dasgupta i in. "Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy". Cancers 11, nr 9 (7.09.2019): 1327. http://dx.doi.org/10.3390/cancers11091327.
Pełny tekst źródłaGrégoire, Serge, Lin Xiao, Jianyun Nie, Xiaohong Zhang, Minghong Xu, Jiarong Li, Jiemin Wong, Edward Seto i Xiang-Jiao Yang. "Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2". Molecular and Cellular Biology 27, nr 4 (11.12.2006): 1280–95. http://dx.doi.org/10.1128/mcb.00882-06.
Pełny tekst źródłaHeppt, Markus V., Anja Wessely, Eva Hornig, Claudia Kammerbauer, Saskia A. Graf, Robert Besch, Lars E. French i in. "HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma". International Journal of Molecular Sciences 23, nr 2 (13.01.2022): 849. http://dx.doi.org/10.3390/ijms23020849.
Pełny tekst źródłaTurgeon, Naomie, Julie Moore Gagné, Mylène Blais, Fernand-Pierre Gendron, François Boudreau i Claude Asselin. "The acetylome regulators Hdac1 and Hdac2 differently modulate intestinal epithelial cell dependent homeostatic responses in experimental colitis". American Journal of Physiology-Gastrointestinal and Liver Physiology 306, nr 7 (1.04.2014): G594—G605. http://dx.doi.org/10.1152/ajpgi.00393.2013.
Pełny tekst źródłaGuise, Amanda J., Todd M. Greco, Irene Y. Zhang, Fang Yu i Ileana M. Cristea. "Aurora B-dependent Regulation of Class IIa Histone Deacetylases by Mitotic Nuclear Localization Signal Phosphorylation". Molecular & Cellular Proteomics 11, nr 11 (2.08.2012): 1220–29. http://dx.doi.org/10.1074/mcp.m112.021030.
Pełny tekst źródłaHan, Ying, Le Chen, Jingyun Liu, Jie Chen, Chunyang Wang, Yu Guo, Xuebin Yu, Chenghong Zhang, Haiying Chu i Haiying Ma. "A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway". Molecules 27, nr 13 (29.06.2022): 4160. http://dx.doi.org/10.3390/molecules27134160.
Pełny tekst źródłaKraft, Fabian B., Maria Hanl, Felix Feller, Linda Schäker-Hübner i Finn K. Hansen. "Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy". Pharmaceuticals 16, nr 3 (25.02.2023): 356. http://dx.doi.org/10.3390/ph16030356.
Pełny tekst źródłaLewis, A., B. Pan-Castillo, G. Berti, C. Felice, H. Gordon, R. Gadhok, A. Minicozzi i in. "DOP23 Single-cell RNA sequencing identifies an important role for class I histone-deacetylase enzymes in intestinal myofibroblasts from patients with Crohn’s Disease strictures". Journal of Crohn's and Colitis 15, Supplement_1 (1.05.2021): S062. http://dx.doi.org/10.1093/ecco-jcc/jjab073.062.
Pełny tekst źródłaAriffin, Juliana K., Kaustav das Gupta, Ronan Kapetanovic, Abishek Iyer, Robert C. Reid, David P. Fairlie i Matthew J. Sweet. "Histone Deacetylase Inhibitors Promote Mitochondrial Reactive Oxygen Species Production and Bacterial Clearance by Human Macrophages". Antimicrobial Agents and Chemotherapy 60, nr 3 (28.12.2015): 1521–29. http://dx.doi.org/10.1128/aac.01876-15.
Pełny tekst źródłaGuenther, Matthew G., Orr Barak i Mitchell A. Lazar. "The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3". Molecular and Cellular Biology 21, nr 18 (15.09.2001): 6091–101. http://dx.doi.org/10.1128/mcb.21.18.6091-6101.2001.
Pełny tekst źródłaCao, Biyin, Mingyun Shen, Depei Wu, Jianhong Du, Jingyu Zhu, Suning Chen, Aining Sun i in. "The Proteasomal Inhibitor Clioquinol Induces Apoptosis in Leukemia and Myeloma Cells by Inhibiting Histone Deacetylase Activity." Blood 120, nr 21 (16.11.2012): 2449. http://dx.doi.org/10.1182/blood.v120.21.2449.2449.
Pełny tekst źródłaKim, Min Young, Bowen Yan, Suming Huang i Yi Qiu. "Regulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis". International Journal of Molecular Sciences 21, nr 22 (11.11.2020): 8460. http://dx.doi.org/10.3390/ijms21228460.
Pełny tekst źródłaTang, Jinhua, Yanli Yan, Ting C. Zhao, George Bayliss, Haidong Yan i Shougang Zhuang. "Class I histone deacetylase activity is required for proliferation of renal epithelial cells". American Journal of Physiology-Renal Physiology 305, nr 3 (1.08.2013): F244—F254. http://dx.doi.org/10.1152/ajprenal.00126.2013.
Pełny tekst źródłaMoreth, Kristin, Daniel Riester, Christian Hildmann, René Hempel, Dennis Wegener, Andreas Schober i Andreas Schwienhorst. "An active site tyrosine residue is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzyme". Biochemical Journal 401, nr 3 (12.01.2007): 659–65. http://dx.doi.org/10.1042/bj20061239.
Pełny tekst źródłaHamoud, Mohamed M. S., Sravani Pulya, Nermine A. Osman, Yamini Bobde, Abdalla E. A. Hassan, Hanan A. Abdel-Fattah, Balaram Ghosh i Amany M. Ghanim. "Design, synthesis, and biological evaluation of novel nicotinamide derivatives as potential histone deacetylase-3 inhibitors". New Journal of Chemistry 44, nr 23 (2020): 9671–83. http://dx.doi.org/10.1039/d0nj01274b.
Pełny tekst źródłaWeiss, Ulrike, Moritz Möller, Sayed Adham Husseini, Christine Manderscheid, Julia Häusler, Gerd Geisslinger i Ellen Niederberger. "Inhibition of HDAC Enzymes Contributes to Differential Expression of Pro-Inflammatory Proteins in the TLR-4 Signaling Cascade". International Journal of Molecular Sciences 21, nr 23 (25.11.2020): 8943. http://dx.doi.org/10.3390/ijms21238943.
Pełny tekst źródłaDing, Jianming (Diane), Masaki Ri, Tomoko Narita, Ayako Masaki, Fumiko Mori, Asahi Ito, Shigeru Kusumoto i in. "Reduced Expression of HDAC3 Contributes to the Resistance Against HDAC Inhibitor, Vorinostat (SAHA) in Mature Lymphoid Malignancies". Blood 120, nr 21 (16.11.2012): 1342. http://dx.doi.org/10.1182/blood.v120.21.1342.1342.
Pełny tekst źródłaDi Giorgio, Eros, Andrea Clocchiatti, Sara Piccinin, Andrea Sgorbissa, Giulia Viviani, Paolo Peruzzo, Salvatore Romeo i in. "MEF2 Is a Converging Hub for Histone Deacetylase 4 and Phosphatidylinositol 3-Kinase/Akt-Induced Transformation". Molecular and Cellular Biology 33, nr 22 (16.09.2013): 4473–91. http://dx.doi.org/10.1128/mcb.01050-13.
Pełny tekst źródłaElbatrawy, Omnia R., Mohamed Hagras, Moshira A. El Deeb, Fatimah Agili, Maghawry Hegazy, Ahmed A. El-Husseiny, Mahmoud Mohamed Mokhtar, Samy Y. Elkhawaga, Ibrahim H. Eissa i Samar El-Kalyoubi. "Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors". Pharmaceuticals 16, nr 7 (6.07.2023): 966. http://dx.doi.org/10.3390/ph16070966.
Pełny tekst źródłaLuo, Yuxiang, i Huilin Li. "Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)". International Journal of Molecular Sciences 21, nr 22 (22.11.2020): 8828. http://dx.doi.org/10.3390/ijms21228828.
Pełny tekst źródłaRizzotto, Lara, Arianna Bottoni, Tzung-Huei Lai, Chaomei Liu, Pearlly S. Yan, Hatice G. Ozer, Rosa Lapalombella i in. "Role of Histone Deacetylase-Mediated Gene Silencing in Chronic Lymphocytic Leukemia Progression". Blood 128, nr 22 (2.12.2016): 2705. http://dx.doi.org/10.1182/blood.v128.22.2705.2705.
Pełny tekst źródłaGomis-Coloma, Clara, Sergio Velasco-Aviles, Jose A. Gomez-Sanchez, Angeles Casillas-Bajo, Johannes Backs i Hugo Cabedo. "Class IIa histone deacetylases link cAMP signaling to the myelin transcriptional program of Schwann cells". Journal of Cell Biology 217, nr 4 (22.02.2018): 1249–68. http://dx.doi.org/10.1083/jcb.201611150.
Pełny tekst źródłaPsilopatis, Iason, Kleio Vrettou, Florian Nima Fleckenstein i Stamatios Theocharis. "The Impact of Histone Modifications in Endometriosis Highlights New Therapeutic Opportunities". Cells 12, nr 9 (23.04.2023): 1227. http://dx.doi.org/10.3390/cells12091227.
Pełny tekst źródłaHyndman, Kelly A., Malgorzata Kasztan, Luciano D. Mendoza i Sureena Monteiro-Pai. "Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation". American Journal of Physiology-Renal Physiology 316, nr 5 (1.05.2019): F875—F888. http://dx.doi.org/10.1152/ajprenal.00499.2018.
Pełny tekst źródłaMayr, Christian, Tobias Kiesslich, Sara Erber, Dino Bekric, Heidemarie Dobias, Marlena Beyreis, Markus Ritter i in. "HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer". Cancers 13, nr 15 (31.07.2021): 3862. http://dx.doi.org/10.3390/cancers13153862.
Pełny tekst źródłaMinisini, Martina, Emiliano Dalla, Vanessa Tolotto i Claudio Brancolini. "Abstract B014: The role of HDAC-MEF2 axis in the epigenetic control of immune tumoral microenvironment". Cancer Research 82, nr 23_Supplement_2 (1.12.2022): B014. http://dx.doi.org/10.1158/1538-7445.cancepi22-b014.
Pełny tekst źródłaShobaki, Nour, Pankaj Gaur, Rahul Nadre, Vivek Verma, Peter Ordentlich, Lei Wang, Nazli Jafarzadeh i in. "Abstract LB566: Class 1 HDAC inhibition induces antitumor immunity by NF-kB-mediated enhanced metabolic fitness and generation of unique effector function enriched memory CD8 T cell subtype". Cancer Research 82, nr 12_Supplement (15.06.2022): LB566. http://dx.doi.org/10.1158/1538-7445.am2022-lb566.
Pełny tekst źródłaMankidy, Rishikesh, Douglas V. Faller, Michael S. Boosalis, Regine Bohacek i Susan P. Perrine. "Mechanisms of γ-Globin Gene Promoter Activation by HBF-Inducing Short Chain Fatty Acid Derivatives." Blood 106, nr 11 (16.11.2005): 826. http://dx.doi.org/10.1182/blood.v106.11.826.826.
Pełny tekst źródłaShearstone, Jeffrey R., John H. van Duzer, Simon S. Jones i Matthew Jarpe. "Pharmacological Inhibition Of Histone Deacetylase (HDAC) 1, 2 Or 3 Have Distinct Effects On Cellular Viability, Erythroid Differentiation, and Fetal Globin (HbG) Induction". Blood 122, nr 21 (15.11.2013): 564. http://dx.doi.org/10.1182/blood.v122.21.564.564.
Pełny tekst źródłaBradbury, Charlotte A., Farhat L. Khanim, Priyanka Mehta, Rachel E. Hayden, Charles F. Craddock, Chris M. Bunce i Bryan M. Turner. "Characterisation of Histone Deacetylase (HDAC) Expression Profiles in Acute Myeloid Leukaemia: A Basis for the Development of Targeted Therapy Using Histone Deacetylase Inhibitors." Blood 104, nr 11 (16.11.2004): 1123. http://dx.doi.org/10.1182/blood.v104.11.1123.1123.
Pełny tekst źródłaYuliana, Ana, Huei-Fen Jheng, Satoko Kawarasaki, Wataru Nomura, Haruya Takahashi, Takeshi Ara, Teruo Kawada i Tsuyoshi Goto. "β-adrenergic Receptor Stimulation Revealed a Novel Regulatory Pathway via Suppressing Histone Deacetylase 3 to Induce Uncoupling Protein 1 Expression in Mice Beige Adipocyte". International Journal of Molecular Sciences 19, nr 8 (17.08.2018): 2436. http://dx.doi.org/10.3390/ijms19082436.
Pełny tekst źródłaMishra, Anjali, Krista M. D. La Perle, Laura Sullivan, Gregory H. Sams, Douglas P. Curphey, Kathleen McConnell, Jun Qi i in. "Increased Expression Of IL-15 Promotes Cutaneous T-Cell Lymphomagenesis Via The Upregulation Of Histone Deacetylases: Evidence For Successful Preclinical Targeting". Blood 122, nr 21 (15.11.2013): 1826. http://dx.doi.org/10.1182/blood.v122.21.1826.1826.
Pełny tekst źródłaSoflaei, Sara Saffar, Amir Abbas Momtazi-Borojeni, Muhammed Majeed, Giuseppe Derosa, Pamela Maffioli i Amirhossein Sahebkar. "Curcumin: A Natural Pan-HDAC Inhibitor in Cancer". Current Pharmaceutical Design 24, nr 2 (5.04.2018): 123–29. http://dx.doi.org/10.2174/1381612823666171114165051.
Pełny tekst źródłaAlamdari, Nima, Ira J. Smith, Zaira Aversa i Per-Olof Hasselgren. "Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle". American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 299, nr 2 (sierpień 2010): R509—R520. http://dx.doi.org/10.1152/ajpregu.00858.2009.
Pełny tekst źródłaKafeel, Muhammad I., Boris Avezbakiyev, Chi Chen, Yiwu Sun, Chenthil Rathnasabapathy, M. Kalavar, Zili He, Jack Burton, Stephen M. Lichter i Jen-Chin Wang. "Histone Deacetylase Activity In Chronic Lymphocytic Leukemia." Blood 116, nr 21 (19.11.2010): 4622. http://dx.doi.org/10.1182/blood.v116.21.4622.4622.
Pełny tekst źródła